Andrew Clark

 
 

Andrew Clark advises strategic buyers and sellers and private equity firms (together with their portfolio companies) on complex and cross-border M&A transactions across industries, including technology, biotech and pharmaceuticals, and consumer and entertainment.

Mr. Clark guides his clients’ most important corporate transactions at every stage of growth and investment, including:

  • Mergers and acquisitions
  • Private equity
  • Joint ventures
  • Corporate governance
  • Securities laws matters

Mr. Clark, who is qualified to practice both US and UK law, draws on his experience steering strategic and private equity-backed transactions in the US and Europe to deliver practical, commercially savvy counsel to clients in a range of industries.

Prior to joining Latham, Mr. Clark worked on secondment at a world-leading R&W insurance underwriter. While there, he helped underwrite transactions with an aggregate value exceeding US$15 billion.

Mr. Clark currently serves as Global Co-Chair of Latham’s LGBTQ Lawyers Group and is a member of the firm’s Training and Career Enhancement Committee.

Mr. Clark’s representative transactions include advising:

Technology
  • Redemption Games in its acquisition by AppLovin
  • Insomniac Games in its acquisition by Sony Interactive Entertainment
  • System1 in its acquisition of Infospace and other acquisitions, equity financing transactions, and general corporate matters
  • Marlin Equity Partners in its acquisitions of:
    • Inkling Systems
    • Skuid
    • Hot Schedules
    • Fourth Limited
  • Expedia in its acquisition of SilverRail Technologies
Private Equity
  • Catterton Partners in its combination with L Capital and L Real Estate, the private equity operations of LVMH and Groupe Arnault, to form the joint venture, L Catterton
  • The Carlyle Group in its acquisition of the Chesapeake paperboard packaging business, the subsequent merger of such business with Multi-Packaging Solutions group and the ultimate initial public offering of the merged group
  • Shamrock Capital on the sale of its ownership stake in Consilio, a provider of eDiscovery, document review, and legal consulting services
  • Mayfair Equity partners in its acquisition of Pixomondo, an international visual effects company
  • Transom Capital in its:
    • Acquisition of Beauty Quest Group
    • Disposal of Martin Audio
    • Disposal of Pelco
  • Leonard Green & Partners in its acquisitions of or investments in:
    • Caliber Collision
    • Wrench Group
    • CPA Global
    • Omnia Partners
  • Onex Corporation in its acquisition of Survitec Group
Biotech & Pharmaceuticals
  • GRAIL in its sale to Illumina for US$8 billion
  • Allergan PLC in the US$40.5 billion sale of its Global Generic Pharmaceuticals Business to Teva
  • Sobi in its US$1.5 billion acquisition of RSV Products from AstraZeneca
  • Multiple pharmaceutical companies in the acquisition or disposal of FDA Priority Review Vouchers
Consumer & Entertainment
  • Cast & Crew in its acquisition of multiple businesses, including:
    • Media Services, a payroll and production management solutions company
    • Sargent-Disc, a UK-based provider of film and television payroll, accounting, software, and services
  • Nike in its sale of the Hurley brand
  • Sony Pictures Entertainment in its purchase of AT&T’s minority interest in their joint venture that owned Game Show Network
  • Stuff Media in connection with its sale to iHeart Media
  • Advantage Sales & Marketing on the establishment of its European joint venture with the Smollan Group
  • Cremo in its acquisition by Edgewell Personal Care
 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.